California Resources Corp
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Francisco J. Leon
- Full Time Employees
- 2,500
- Sector
- Energy
- Industry
- Oil & Gas Exploration & Production
- Address
- 1 World Trade Center Long Beach CA United States of America 90831
- IPO Date
- Oct 28, 2020
- CIK
- 0001609253
- Website
- crc.com
- Similar Companies
- Business
- California Resources Corporation (CRC) is an independent energy company engaged in the acquisition, exploration, development, and production of oil, natural gas, and natural gas liquids primarily in California. The company operates across key segments including exploration and production, low carbon solutions, and energy transition initiatives, offering crude oil, natural gas, and CO2 sequestration services; it focuses on conventional and unconventional reservoirs in onshore and offshore assets such as the Elk Hills Oil Field, Wilmington Oil Field, and Ventura Basin. CRC targets industrial and commercial customers in the energy sector, with operations concentrated in California and select U.S. regions, headquartered in Long Beach, California, since its founding in 2014 following the spin-off from Occidental Petroleum Corporation. Core products and services encompass upstream oil and gas production from mature fields using enhanced oil recovery techniques like steam flooding and waterflooding; natural gas processing and marketing; and low carbon mineral and energy solutions including carbon capture, utilization, and storage (CCUS) projects aimed at net-zero emissions goals. The company manages a portfolio of high-quality assets covering approximately 2.4 million net acres, producing around 150,000 barrels of oil equivalent per day, with brands and technologies centered on proprietary extraction methods and renewable natural gas development. CRC also provides midstream services for transportation and storage, serving refineries, utilities, and export markets along the U.S. West Coast. In recent developments, CRC completed the acquisition of the remaining 50.1% interest in Aera Energy LLC in October 2024, significantly expanding its asset base and production capacity to over 180,000 barrels of oil equivalent per day; this strategic move followed an initial joint venture and enhanced CRC's position as California's largest oil producer. The company launched its $1 billion Salt Creek CCUS project in 2025, marking a major expansion into carbon management with capacity for 4.5 million metric tons of CO2 storage annually, supported by partnerships with ExxonMobil and Calpine. Additionally, CRC secured a $500 million sustainability-linked financing round in early 2025 and announced plans to divest non-core assets to fund energy transition efforts, reflecting a shift toward integrated low-carbon operations amid regulatory changes in California.
Company News
/C O R R E C T I O N - AbbVie/
AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio
ESMO 2026 Presentations Deepen the Evidence Base for Natera's Oncology Portfolio and Leadership in Ultrasensitive MRD Technology
Incyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests
Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests
Canter Resources Grants Options
Should Value Investors Buy California Resources (CRC) Stock?
Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer
California Resources Corporation Schedules Third Quarter 2026 Earnings Conference Call
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
Head to Head Comparison: California Resources (NYSE:CRC) versus Kinetik (NYSE:KNTK)
Freenome: SimpleScreen CRC Unlocks A 50M Patient TAM, Bypassing Competition
California Resources to Divest Uinta Basin Assets for $90 Million
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
California Resources Corporation Announces Divestiture of Uinta Basin Assets
Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso's HARMONi-2 Study Condu
Why Is California Resources (CRC) Up 2.7% Since Last Earnings Report?